Role of Extracellular RNA and TLR3‐Trif Signaling in Myocardial Ischemia–Reperfusion Injury
Top Cited Papers
Open Access
- 27 January 2014
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of the American Heart Association
- Vol. 3 (1), e000683
- https://doi.org/10.1161/jaha.113.000683
Abstract
Background: Toll‐like receptor 3 ( TLR 3) was originally identified as the receptor for viral RNA and represents a major host antiviral defense mechanism. TLR 3 may also recognize extracellular RNA (ex RNA ) released from injured tissues under certain stress conditions. However, a role for ex RNA and TLR 3 in the pathogenesis of myocardial ischemic injury has not been tested. This study examined the role of ex RNA and TLR 3 signaling in myocardial infarction (MI), apoptosis, inflammation, and cardiac dysfunction during ischemia‐reperfusion (I/R) injury. Methods and Results: Wild‐type ( WT ), TLR 3 −/− , Trif −/− , and interferon ( IFN ) α/β receptor‐1 deficient ( IFNAR 1 −/− ) mice were subjected to 45 minutes of coronary artery occlusion and 24 hours of reperfusion. Compared with WT , TLR 3 −/− or Trif −/− mice had smaller MI and better preserved cardiac function. Surprisingly, unlike TLR (2/4)‐MyD88 signaling, lack of TLR 3‐Trif signaling had no impact on myocardial cytokines or neutrophil recruitment after I/R, but myocardial apoptosis was significantly attenuated in Trif −/− mice. Deletion of the downstream IFNAR 1 had no effect on infarct size. Importantly, hypoxia and I/R led to release of RNA including micro RNA from injured cardiomyocytes and ischemic heart, respectively. Necrotic cardiomyocytes induced a robust and dose‐dependent cytokine response in cultured cardiomyocytes, which was markedly reduced by RNase but not DNase, and partially blocked in TLR 3‐deficient cardiomyocytes. In vivo, RNase administration reduced serum RNA level, attenuated myocardial cytokine production, leukocytes infiltration and apoptosis, and conferred cardiac protection against I/R injury. Conclusion: TLR 3‐Trif signaling represents an injurious pathway during I/R. Extracellular RNA released during I/R may contribute to myocardial inflammation and infarction.Keywords
This publication has 56 references indexed in Scilit:
- MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory responseProceedings of the National Academy of Sciences of the United States of America, 2012
- Nonhematopoietic Toll-Like Receptor 2 Contributes to Neutrophil and Cardiac Function Impairment During Polymicrobial SepsisShock, 2011
- Myocardial Ischemia Activates an Injurious Innate Immune Signaling via Cardiac Heat Shock Protein 60 and Toll-like Receptor 4Published by Elsevier BV ,2011
- Circulating microRNAs are new and sensitive biomarkers of myocardial infarctionEuropean Heart Journal, 2010
- Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humansEuropean Heart Journal, 2010
- MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologueCardiovascular Research, 2009
- A critical link between Toll-like receptor 3 and type II interferon signaling pathways in antiviral innate immunityProceedings of the National Academy of Sciences of the United States of America, 2008
- TLR3 is an endogenous sensor of tissue necrosis during acute inflammatory eventsThe Journal of Experimental Medicine, 2008
- Extracellular RNA constitutes a natural procoagulant cofactor in blood coagulationProceedings of the National Academy of Sciences of the United States of America, 2007
- Pathogen Recognition and Innate ImmunityCell, 2006